This episode of Pharma Pulse covers the FDA’s approval of a rapid one-minute HIV self-test, the US government’s decision to delay tariffs on pharmaceutical exports from Singapore, and CVS Pharmacy’s ...

As healthcare shifts from fee-for-service to value-based models, success now depends on keeping patients healthy, not just ...

Despite these moving parts and regardless of the results, Singapore's exports to the US are still subject to 10% baseline ...

In the third part of her Pharma Commerce video interview, Linda Malek, JD, partner at Crowell & Moring, explains how ...

This episode of Pharma Pulse covers the nationwide Kaiser Permanente strike involving more than 40,000 healthcare workers, Takeda’s new AI-driven antibody discovery partnership with Nabla Bio, and the ...

Dave Malenfant, healthcare supply chain expert, discusses the ramifications of a 100% tariff on branded and patented drugs entering the US.

In the second part of her Pharma Commerce video interview, Linda Malek, JD, partner at Crowell & Moring, notes that by ...

Novo Nordisk's Bloomington facility received an OAI label from the FDA due to compliance issues, including contamination by ...

Krenar Komoni, founder and CEO of Tive, predicts that AI-driven automation and its accelerating impact on pharmaceutical ...

This episode of Pharma Pulse covers how recent CDC layoffs are fueling concerns about disease surveillance, Ypsomed’s new autoinjector manufacturing site in North Carolina, and Lupin’s $250 million ...

Lupin, a manufacturer of complex generics, will be constructing a new state-of-the-art pharma manufacturing facility in Coral ...